This acquisition holds significance to me because of all the products listed in the pipeline-I had no idea. Check them out, some in phase 2 and 3 already. Granted, many are for Alz., but I am reading more and more about the relationship between neuro problems and what helps one disorder may well help another.

Additionally, this transaction (and underlying research/products in the pipeline) further support what seems to be an increasingly prevalent theory that neuro disorders have an immune component (if not actual cause). Here's the link:

http://online.wsj.com/article/BT-CO-...17-707384.html